Arkolith/Insider Trading/ERNA/Form 4

Gurrola Sandra M

Sr. VP of FinanceEterna Therapeutics Inc. (ERNA) · full profile →Form 4 · filed Jun 25, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 21, 2024Option exercise(M)437——1K
Jun 21, 2024Tax withholding(F)180$1.94$3491K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 21, 2024Option exercise(M)437—$0437

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-025105) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML